No phaseNot yet recruiting

Study to Investigate Asparagus Racemosus Extract (Shaktiva™) for Psychological Symptoms in Perimenopausal Women

Effect of a Standardised Extract of Asparagus Racemosus (Shaktiva™) on Psychological and Physical Symptoms in Perimenopausal Women: A Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial

Sponsor
Liaquat University of Medical & Health Sciences (Academic or other)
Enrolment
100 planned
Conditions
Perimenopausal Disorder
Interventions
Asparagus racemosus Extract (Shaktiva™); Placebo
Ages
adults
Registry
NCT07853560

From the registry

Perimenopause is commonly associated with psychological symptoms, including low mood, anxiety, and stress, which can negatively affect wellbeing and quality of life. This study will investigate whether Shaktiva™, a standardised extract of Asparagus racemosus (Shatavari), can improve psychological symptoms in perimenopausal women. This is an 8-week, multicentre, randomized, double-blind, placebo-controlled clinical trial involving 100 perimenopausal women. Participants will be randomly assigned to receive either Shaktiva™ 300 mg once daily or a matching placebo. The study will primarily evaluate changes in depression, anxiety, and stress. It will also assess mood and affect, mental wellbeing, menopausal symptoms, sleep, quality of life, safety, and selected hormones.

Primary outcomes

  • Change in DASS-42 Depression Subscales Scores
Full record on ClinicalTrials.gov